GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jubilant Pharmova Ltd (BOM:530019) » Definitions » Institutional Ownership

Jubilant Pharmova (BOM:530019) Institutional Ownership : 10.70% (As of Apr. 26, 2025)


View and export this data going back to 1995. Start your Free Trial

What is Jubilant Pharmova Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Jubilant Pharmova's institutional ownership is 10.70%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Jubilant Pharmova's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Jubilant Pharmova's Float Percentage Of Total Shares Outstanding is 0.00%.


Jubilant Pharmova Institutional Ownership Historical Data

The historical data trend for Jubilant Pharmova's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jubilant Pharmova Institutional Ownership Chart

Jubilant Pharmova Historical Data

The historical data trend for Jubilant Pharmova can be seen below:

2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31
Institutional Ownership 7.67 7.73 8.08 9.10 9.35 9.62 10.64 10.66 10.66 10.70

Jubilant Pharmova Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Jubilant Pharmova Business Description

Traded in Other Exchanges
Address
1A, Sector 16A, Noida, UP, IND, 201301
Jubilant Pharmova Ltd is an integrated pharmaceutical company. The company operates in the following segments; Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research, Development and Manufacturing Organisation; and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment which specializes in developing, manufacturing, commercializing, and distributing therapeutic agents in the nuclear medicine domain. Geographically, it derives a majority of its revenue from the Americas and Europe and the rest from India and the Rest of the world.

Jubilant Pharmova Headlines

No Headlines